Cardiovascular system adaptation (blood pressure reduction)

The target 'Cardiovascular system adaptation (blood pressure reduction)' refers to the complex physiological mechanisms involved in regulating blood pressure in the body. This is not a single molecular target but rather a comprehensive process involving multiple systems, pathways, and molecular targets. Key regulatory systems include the Renin-Angiotensin-Aldosterone System (RAAS), the Natriuretic Peptide System (involving ANP, BNP, CNP, and their receptors NPR1, NPR2, NPR3), and various renal ion channels and transporters (e.g., NHE3, NKCC2, NCC, ENaC, Pendrin). Blood pressure regulation is also influenced by genetic and epigenetic factors, such as specific microRNAs and lncRNA polymorphisms. Understanding these integrated mechanisms is crucial for developing therapeutic strategies to reduce blood pressure and manage conditions like hypertension and chronic heart failure.

Mechanisms of action for therapies designed to achieve cardiovascular system adaptation (blood pressure reduction) involve modulating key regulatory systems such as the Renin-Angiotensin-Aldosterone System (RAAS) and the Natriuretic Peptide System, inhibiting specific enzymes (e.g., neprilysin), modulating renal ion channels and transporters, and potentially targeting specific 'hub genes' involved in blood pressure regulation.